US EditionThis Nancy Pelosi stock breaks out after mega $200 million deal
Summary by Finbold
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
This Nancy Pelosi stock breaks out after mega $200 million deal
Summary⚈ Tempus AI jumped 15% after a $200M AI oncology deal with AstraZeneca and Pathos AI.⚈ The deal boosts cancer drug discovery using Tempus’s de-identified data and AI model development.⚈ Pelosi’s Tempus investment is up 35%, her only profitable 2025 trade, with analysts targeting $62.33. The share price of health technology company Tempus AI (NASDAQ: TEM) has soared by double digits, fueled by positive investor reaction to a blockbuster…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
